Recently, transcription factors Sp1, Sp3 and Egr-1 have been identified as potent regulators of MT1-MMP expression in prostate cancer, endothelial and glomerular mesangial cells [24,32,33]. The gene discussed is SP1; the disease is prostate carcinoma.